Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. It provides fertility research and treatment services, tertiary level prenatal diagnostic services, low intervention IVF services, and diagnostic ultrasound services. The company operates 22 fertility clinics, 18 specialist women's imaging sites, 5 service centers, 2 specialized diagnostic laboratories, and 3 day hospitals. The company was incorporated in 2014 and is based in Richmond, Australia.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+61-3-94208235
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$150.86 million
Profitability
Miscellaneous
Employees588
Next Earnings DateN/A
OptionableNot Optionable
Monash IVF Group (ASX:MVF) Frequently Asked Questions
What is Monash IVF Group's stock symbol?
Monash IVF Group trades on the ASX under the ticker symbol "MVF."
How often does Monash IVF Group pay dividends? What is the dividend yield for Monash IVF Group?
Monash IVF Group declared a Interim dividend on Tuesday, February 26th. Shareholders of record on Friday, April 5th will be given a dividend of 0.03 per share on Friday, April 5th. This represents a yield of 3.05%. The ex-dividend date of this dividend is Thursday, March 7th. View Monash IVF Group's Dividend History.
Has Monash IVF Group been receiving favorable news coverage?
News headlines about MVF stock have been trending somewhat positive this week, InfoTrie reports. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Monash IVF Group earned a news impact score of 1.9 on InfoTrie's scale. They also gave news stories about the company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
Who are some of Monash IVF Group's key competitors?
Some companies that are related to Monash IVF Group include Polynovo (PNV), Mesoblast (MSB), Resverlogix (RVX), Emerald Health Therapeutics (EMH), Biotest (BIO), Starpharma (SPL), Oxford BioMedica (OXB), Theratechnologies (TH), Neptune Wellness Solutions (NEPT), Senesco Technologies (ELOX), Kodiak Sciences (KOD), OncoCyte (OCX), Paradigm Biopharmaceuticals (PAR), Horizon Discovery Group (HZD) and IMV (IMV).
What other stocks do shareholders of Monash IVF Group own?
Who are Monash IVF Group's key executives?
Monash IVF Group's management team includes the folowing people:
- Mr. Michael D. Knaap, Interim CEO & Company Sec.
- Mr. Brett Comer, Chief Operations Officer
- Dr. Richard Charles Henshaw, Exec. Director
- Mr. Malik Jainudeen, CFO & Company Sec.
- Mr. Pierre Abou Haila, Chief Information Officer
What is Monash IVF Group's stock price today?
One share of MVF stock can currently be purchased for approximately A$1.09.
How big of a company is Monash IVF Group?
Monash IVF Group has a market capitalization of $256.08 million and generates $150.86 million in revenue each year. Monash IVF Group employs 588 workers across the globe.
What is Monash IVF Group's official website?
How can I contact Monash IVF Group?
Monash IVF Group's mailing address is Pelaco Bldg, 1/21-31 Goodwood St, RICHMOND, VIC 3121, Australia. The company can be reached via phone at +61-3-94208235.
MarketBeat Community Rating for Monash IVF Group (ASX MVF)
MarketBeat's community ratings are surveys of what our community members think about Monash IVF Group and other stocks. Vote "Outperform" if you believe MVF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MVF will underperform the S&P 500 over the long term. You may vote once every thirty days.
